SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: Garry K. who wrote (603)4/27/1999 1:09:00 PM
From: Jim Oravetz  Read Replies (1) | Respond to of 2344
 
OT++ try the Biotech Derivatives thread

Subject 26118

Jim



To: Garry K. who wrote (603)4/27/1999 2:32:00 PM
From: William Whitehead Jr.  Respond to of 2344
 
Call Options are a good consideration. One problem with them on the TSE is that there are usually high premiums charged during a run-up (like the last couple of days) and very poor liquidity when price is dropping. Consequently I think buying the stock on margin (30% cash requirement) might be a wiser move.

Whitey,


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News